Compare Dropbox Inc (DBX) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dropbox Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Dropbox Inc trades at $33.32 (market cap $7.41B), while State Street SPDR S&P Biotech ETF trades at $157.36. Which is the better fit depends on your goals.
| DBX | XBI | |
|---|---|---|
Market Cap | $7.41B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $35.00 | $164.28 |
52-Week Low | $22.06 | $86.92 |
Enterprise Value | $10.27B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBX trades at $34.59, down 0.63% today, with a bullish technical signal from moving averages and recent earnings beats. Revenue remains steady at $2.52B for 2025, with a net income margin of 20.16%. The company raised its 2026 outlook after Q2 results, supported by core file-sync-and-share growth and AI expansion. Cash flow from operations improved to $952M in 2025, though net cash flow was negative due to financing activities.
The outlook is mixed; strong profitability and bullish analyst coverage contrast with high debt levels and negative shareholder equity. Risks include competitive pressures and reliance on sustained user growth. With 37.5% of analysts rating it a buy, the stock offers growth potential but requires monitoring of balance sheet health and execution risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dropbox Inc
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
